A federal judge said a Maine doctor disciplined for prescribing ivermectin and speaking against COVID orthodoxy can take her First Amendment case to trial.
Story Highlights
- A U.S. District Court ruling allows Dr. Meryl Nass’s free-speech lawsuit to proceed.
- Maine’s medical board pursued her for public COVID statements it labeled “misinformation”.
- The board’s demand for a psychological evaluation was later vacated by a state court.
- The case spotlights government overreach and due process in professional discipline.
Judge Opens Door for Free-Speech Challenge
Chief U.S. District Judge Lance E. Walker ruled that Dr. Meryl Nass’s lawsuit against Maine’s medical board may proceed, rejecting the board’s bid to end the case early. Court filings show the board pursued Nass for public statements about COVID-19 and its treatment that it said clashed with its “anti-misinformation” position. The federal case centers on whether a state agency may punish a doctor’s speech on public policy while staying within the limits of the First Amendment and due process.
The ruling does not decide the final outcome. It clears the path for discovery and trial on claims that the state targeted protected speech. Nass argues regulators used vague standards to silence her views on COVID policy and early outpatient treatments. The board denies wrongdoing and says it enforced professional rules. The judge’s order signals that, at minimum, Nass has alleged enough to test those claims in court with evidence and cross-examination.
Board Sanctions and Extraordinary Demands Face Scrutiny
The board’s public record shows it suspended Nass’s license in January 2022 and later extended sanctions, citing alleged unprofessional conduct and rule violations. It also ordered her to undergo a neuropsychological evaluation, a rare and invasive step. In October 2025, the Maine Superior Court vacated that evaluation order as arbitrary, undercutting one of the board’s most aggressive moves against her. That state-court rebuke now sits alongside the federal judge’s green light, raising sharper questions about overreach.
Federal filings describe how the board tied its case to Nass’s speech about COVID treatments and the federal response, labeling her views “misinformation” under its policy. That framing matters. The United States Constitution places strict limits on punishing speech based on viewpoint. Courts have also recognized doctors may prescribe approved drugs for off-label uses, which is common and legal when done to medical standards. The legal fight will test where professional regulation ends and censorship begins, and whether Maine respected clear, objective standards.
What This Means for Doctors, Patients, and Accountability
This dispute sits inside a larger national tug-of-war over COVID-era authority. Some boards tried to police doctors’ speech and early-treatment protocols. Courts have pushed back when rules were vague or targeted viewpoints, including cases restricting state efforts to punish doctors for sharing nonconforming COVID opinions with patients. The Nass case adds force to concerns many conservatives share: unelected boards used “misinformation” labels to chill debate, rather than meet dissent with data and open argument.
💉 COVID Crimes / Medical Tyranny
Federal Judge Green-lights Lawsuit from Maine Doctor Meryl Nass – who was harassed, smeared, had her license suspended by Maine's Board of Licensure in 2022 because she prescribed Ivermectin and Hydroxychloroquinehttps://t.co/kqXXKvr2La
— Biff Smallberries (@B_Smallberries) August 25, 2026
For patients, the stakes are choice and trust. For doctors, the stakes are clarity and fairness. When agencies blur the line between bad advice and disfavored opinion, they risk crushing good-faith judgment and innovation. The federal court’s ruling ensures the facts will see sunlight. If Nass proves censorship and arbitrary action, it will mark a win for free speech, medical autonomy, and the basic due process that protects every American from government overreach.
Sources:
medpagetoday.com, mainepublic.org, govinfo.gov, quackwatch.org, paulcahill.ca
